FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19492911000001103: Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66087301000001114 Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66087401000001118 Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Is a Linagliptin 5mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has AMP Trajenta 5mg tablets (Boehringer Ingelheim Ltd) true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Linagliptin false Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start